The natural history of secondary progressive multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 9, 2010, Pages 1039-1043

  Koch, Marcus ^a,b   Kingwell, Elaine ^a   Rieckmann, Peter ^a   Tremlett, Helen ^a   Adams, D ^c   Craig, D ^c   Daly, L ^c   Devonshire, V ^c   Hashimoto, S ^c   Hrebicek, O ^c   Hooge, J ^c   Jones, B ^c   Kastrukoff, L ^c   Meckling, S ^c   Oger, J ^c   Parton, D ^c   Paty, D ^c   Smyth, P ^c   Shtybel, W ^c   Traboulsee, T ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CEREBELLAR ATAXIA; DISEASE COURSE; FEMALE; GENDER; HISTORY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; OPTIC NEURITIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; AGE; MIDDLE AGED; MOTOR PERFORMANCE; SEX DIFFERENCE; TIME;

ADULT; AGE FACTORS; AGE OF ONSET; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; SEX FACTORS; TIME FACTORS;

EID: 77956637132     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.208173     Document Type: Article

References (29)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-31.
2. Rovaris M, Confavreux C, Furlan R, et al. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol 2006;5:343-54.
3. Minderhoud JM, van der Hoeven JH, Prange AJ. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand 1988;78:10-15.
4. Stankoff B, Mrejen S, Tourbah A, et al. Age at onset determines the occurrence of the progressive phase of multiple sclerosis. Neurology 2007;68:779-81. (Pubitemid 46667906)
5. Koch M, Mostert J, Heersema D, et al. Progression in multiple sclerosis: further evidence of an age dependent process. J Neurol Sci 2007;255:35-41. (Pubitemid 46414019)
6. Tremlett H, Yinshan Z, Devonshire V. Natural history of secondary-progressive multiple sclerosis. Mult Scler 2008;14:314-24. (Pubitemid 351676426)
7. Sweeney VP, Sadovnick AD, Brandejs V. Prevalence of multiple sclerosis in British Columbia. Can J Neurol Sci 1986;13:47-51. (Pubitemid 16189888)
8. Sadovnick AD, Ebers GC, Wilson RW, et al. Life expectancy in patients attending multiple sclerosis clinics. Neurology 1992;42:991-4.
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31. (Pubitemid 13158528)
10. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-11.
11. Vukusic S, Confavreux C. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. J Neurol Sci 2003;206:135-7. (Pubitemid 36143717)
12. Debouverie M, Louis S, Pittion-Vouyovitch S, et al. Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France. J Neurol 2007;254:1370-5. (Pubitemid 350112325)
13. Bergamaschi R, Berzuini C, Romani A, et al. Predicting secondary progression in relapsing - remitting multiple sclerosis: a Bayesian analysis. J Neurol Sci 2001;189:13-21. (Pubitemid 32776645)
14. Amato MP, Ponziani G, Bartolozzi ML, et al. A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. J Neurol Sci 1999;168:96-106. (Pubitemid 29467426)
15. Koch M, Uyttenboogaart M, van Harten A, et al. Factors associated with the risk of secondary progression in multiple sclerosis. Mult Scler 2008;14:799-803.
16. Trojano M, Avolio C, Manzari C, et al. Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 1995;58:300-6.
17. Riise T, Gronning M, Fernandez O, et al. Early prognostic factors for disability in multiple sclerosis, a European multicenter study. Acta Neurol Scand 1992;85:212-18.
18. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116:117-34. (Pubitemid 23087038)
19. Schwendimann RN, Alekseeva N. Gender issues in multiple sclerosis. Int Rev Neurobiol 2007;79:377-92.
20. Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998;339:285-91.
21. Sicotte NL, Liva SM, Klutch R, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002;52:421-8.
22. Vukusic S, Ionescu I, El Etr M, et al. The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J Neurol Sci 2009;286:114-18.
23. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-7.
24. Compston A, Ebers GC, Lassmann H, et al. McAlpine's multiple sclerosis. 3rd Edn. London: Churchill Livingstone, 1998.
25. Sim FJ, Zhao C, Penderis J, et al. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 2002;22:2451-9. (Pubitemid 37465793)
26. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006;129:595-605. (Pubitemid 43278222)
27. Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007;356:2603-13.
28. Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology 2006;66:172-7.
29. Trojano M, Pellegrini F, Fuiani A, et al. New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol 2007;61:300-6.